VTRS
Viatris Inc
NASDAQ: VTRS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$14.94
-0.20% today
Updated 2026-04-30
Market cap
$17.43B
P/E ratio
—
P/S ratio
1.22x
EPS (TTM)
$-3.00
Dividend yield
3.24%
52W range
$8 – $16
Volume
10.5M
Viatris Inc (VTRS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-24.60%
Operating margin
7.78%
ROE
-21.10%
ROA
1.96%
Debt/equity
0.97x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.61B | $217.28M | 52.34% | 26.53% | 13.48% |
| 2007 | $2.91B | $-1.52B | 40.14% | 12.80% | -52.23% |
| 2008 | $5.14B | $-196.08M | 40.30% | 5.80% | -3.82% |
| 2009 | $5.09B | $232.57M | 40.73% | 10.28% | 4.57% |
| 2010 | $5.45B | $345.12M | 40.68% | 13.24% | 6.33% |
| 2011 | $6.13B | $536.81M | 41.82% | 16.40% | 8.76% |
| 2012 | $6.80B | $640.85M | 42.79% | 16.32% | 9.43% |
| 2013 | $6.91B | $623.70M | 44.00% | 16.43% | 9.03% |
| 2014 | $7.72B | $929.40M | 45.70% | 17.52% | 12.04% |
| 2015 | $9.43B | $847.60M | 44.71% | 15.49% | 8.99% |
| 2016 | $11.08B | $480.00M | 42.40% | 6.31% | 4.33% |
| 2017 | $11.91B | $696.00M | 40.17% | 12.07% | 5.84% |
| 2018 | $11.43B | $352.50M | 35.00% | 7.92% | 3.08% |
| 2019 | $11.50B | $16.80M | 33.89% | 6.22% | 0.15% |
| 2020 | $11.95B | $-669.90M | 31.78% | -1.76% | -5.61% |
| 2021 | $17.89B | $-1.27B | 31.17% | -0.19% | -7.10% |
| 2022 | $16.26B | $2.08B | 39.95% | 9.93% | 12.78% |
| 2023 | $15.43B | $54.70M | 41.74% | 4.97% | 0.35% |
| 2024 | $14.74B | $-634.20M | 38.15% | 0.07% | -4.30% |
| 2025 | $14.30B | $-3.51B | 35.06% | -18.62% | -24.58% |